Axonics Modulation Technologies (AXNX) Coverage Initiated at Morgan Stanley

Equities researchers at Morgan Stanley began coverage on shares of Axonics Modulation Technologies (NASDAQ:AXNX) in a research report issued to clients and investors on Sunday. The firm set an “overweight” rating and a $14.92 price target on the stock. Morgan Stanley’s price target indicates a potential upside of 13.03% from the stock’s current price.

Several other equities analysts have also commented on AXNX. SunTrust Banks assumed coverage on Axonics Modulation Technologies in a research note on Monday, November 26th. They set a “buy” rating and a $20.00 price target on the stock. Bank of America assumed coverage on Axonics Modulation Technologies in a research note on Monday, November 26th. They set a “buy” rating and a $23.00 price target on the stock. Finally, Wells Fargo & Co assumed coverage on Axonics Modulation Technologies in a research note on Monday, November 26th. They set an “outperform” rating and a $22.00 price target on the stock.

Shares of Axonics Modulation Technologies stock traded down $0.20 during trading on Friday, hitting $13.20. 143,071 shares of the stock traded hands, compared to its average volume of 199,673. Axonics Modulation Technologies has a 52-week low of $11.95 and a 52-week high of $17.00.

In other news, Director Bakker Juliet Tammenoms purchased 533,333 shares of the business’s stock in a transaction dated Friday, November 2nd. The shares were purchased at an average price of $15.00 per share, for a total transaction of $7,999,995.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Cormorant Asset Management, Lp bought 133,333 shares of the business’s stock in a transaction on Wednesday, October 31st. The stock was bought at an average price of $15.00 per share, for a total transaction of $1,999,995.00. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 1,533,332 shares of company stock worth $22,999,980.

Axonics Modulation Technologies Company Profile

There is no company description available for Axonics Modulation Technologies Inc

Read More: Moving Average (MA)

Receive News & Ratings for Axonics Modulation Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axonics Modulation Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit